KLK3 and prostate carcinoma: JCO 38:5541–5541 Chi KN, Saad F, Chowdhury S et al (2020) Prostate-specific antigen (PSA) kinetics in patients with advanced prostate cancer treated with apalutamide: Results from the TITAN and SPARTAN studies.